Navalign LLC’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.6K | Hold |
59,865
| – | – | 0.02% | 114 |
|
|
2025
Q1 | $87.4K | Hold |
59,865
| – | – | 0.02% | 113 |
|
|
2024
Q4 | $128K | Sell |
59,865
-15,500
| -21% | -$33K | 0.04% | 115 |
|
|
2024
Q3 | $211K | Hold |
75,365
| – | – | 0.06% | 114 |
|
|
2024
Q2 | $176K | Hold |
75,365
| – | – | 0.06% | 114 |
|
|
2024
Q1 | $337K | Hold |
75,365
| – | – | 0.11% | 101 |
|
|
2023
Q4 | $242K | Hold |
75,365
| – | – | 0.08% | 119 |
|
|
2023
Q3 | $239K | Hold |
75,365
| – | – | 0.09% | 127 |
|
|
2023
Q2 | $375K | Hold |
75,365
| – | – | 0.15% | 89 |
|
|
2023
Q1 | $372K | Hold |
75,365
| – | – | 0.16% | 91 |
|
|
2022
Q4 | $474K | Hold |
75,365
| – | – | 0.2% | 94 |
|
|
2022
Q3 | $814K | Hold |
75,365
| – | – | 0.37% | 50 |
|
|
2022
Q2 | $859K | Buy |
75,365
+1,094
| +1% | +$12.5K | 0.38% | 53 |
|
|
2022
Q1 | $623K | Buy |
74,271
+9,843
| +15% | +$82.6K | 0.26% | 75 |
|
|
2021
Q4 | $961K | Hold |
64,428
| – | – | 0.38% | 54 |
|
|
2021
Q3 | $1.66M | Hold |
64,428
| – | – | 0.7% | 25 |
|
|
2021
Q2 | $1.68M | Buy |
+64,428
| New | +$1.68M | 0.71% | 24 |
|